Blood transfusion in sub-Saharan Africa: understanding the missing gap and responding to present and future challenges

Vox Sanguinis

Volumn 113, Issue 8, 2018, Pages 726-736

  Barro, Lassina ^a,b   Drew, Victor J ^a   Poda, Ghislain G ^c   Tagny, Claude T ^d   El Ekiaby, Magdy ^e   Owusu Ofori, Shirley ^f   Burnouf, Thierry ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b Centre National de Transfusion Sanguine   (Burkina Faso)

^c MINISTÈRE DE LA SANTÉ   (Burkina Faso)

^d UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^e Shabrawishy Hospital   (Egypt)

^f KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

Author keywords

blood; clinical use; sub Saharan Africa; transfusion

Indexed keywords

AFRICA SOUTH OF THE SAHARA; BLOOD COMPONENT; BLOOD SAMPLING; BLOOD TRANSFUSION; ERYTHROCYTE; HEALTH CARE NEED; HUMAN; INFECTION; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; NONHUMAN; PLASMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; BLOOD DONOR; BLOOD SAFETY; STANDARDS; STATISTICS AND NUMERICAL DATA; WORLD HEALTH ORGANIZATION;

AFRICA SOUTH OF THE SAHARA; BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; HUMANS; WORLD HEALTH ORGANIZATION;

EID: 85053438195     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12705     Document Type: Review

References (83)

1. Anonymous: Annex 1 - 19th WHO Model List of Essential Medicines (April 2015); in World Health Organization, (ed). Geneva, Switzerland: World Health Organization, 2015
2. Anonymous: Blood products and related biologicals. Geneva, Switzerland: World Health Organization, 2017. Epub ahead of print [http://www.who.int/bloodproducts/en/] [Last accessed 25 June 2017]
3. Anonymous: Guidelines on management of blood and blood components as essential medicines. WHO Technical report series, No 1004, 2017. 2017. Epub ahead of print [http://apps.who.int/medicinedocs/documents/s23322en/s23322en.pdf] [Last accessed 19 June 2018]
4. Allain JP, Goodrich R: Pathogen reduction of whole blood: utility and feasibility. Transfus Med 2017; 27:320–326
5. Anonymous: The 2016 global status report on blood safety and availability. Geneva, Switzerland: World Health Organisation, 2017
6. Schneider WH: History of blood transfusion in sub-Saharan Africa. Transfus Med Rev 2013; 27:21–28
7. Basu D, Kulkarni R: Overview of blood components and their preparation. Indian J Anaesth 2014; 58:529–537
8. Blajchman M, Shepherd F, Perrault R: Clinical use of blood, blood components and blood products. Can Med Assoc J 1979; 121:33
9. Team WER: Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med 2014; 2014:1481–1495
10. Anonymous: Current status on blood safety and availability in the WHO African Region. WHO 2013. 2017. Epub ahead of print [http://www.who.int/iris/handle/10665/254656] [Last accessed 21 June 2017]
11. Anonymous: 10 Facts on Blood Transfusion. Geneva, Switzerland: World Health Organisation, 2016. Epub ahead of print [http://www.who.int/features/factfiles/blood_transfusion/en/] [Last accessed 25 June 2017]
12. Anonymous: Blood safety. Geneva, Switzerland: World Health Organisation, 2015. Epub ahead of print [http://www.afro.who.int/en/blood-safety.html] [Last accessed 25 June 2017]
13. Bloch EM, Vermeulen M, Murphy E: Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev 2012; 26:164–180
14. Anonymous: Global database on blood safety (GDBS) reports 2011. World Health Organization. Geneva, Switzerland: World Health Organisation, 2011. Epub ahead of print [http://www.who.int/bloodsafety/global_database/GDBS_Summary_Report_2011.pdf?ua=1] [Last accessed 25 June 2017]
15. Bugge H, Karlsen N, Oydna E, et al.: A study of blood transfusion services at a district hospital in Malawi. Vox Sang 2013; 104:37–45
16. Tagny CT, Mbanya D, Tapko JB, et al.: Blood safety in Sub-Saharan Africa: a multi-factorial problem. Transfusion 2008; 48:1256–1261
17. Tapko J, Mainuka P, Diarra-Nama A: Status of Blood Safety in the WHO African Region: Report of the 2006 Survey. Brazzaville, Republic of Congo: WHO Regional Office for Africa, 2006
18. Ala F, Allain J-P, Bates I, et al.: External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. PLoS Med 2012; 9:e1001309
19. Anonymous: Assessment criteria for national blood regulatory systems. Geneva, Switzerland: WHO., 2012. Epub ahead of print [http://www.who.int/bloodproducts/NationalBloodRegSystems.pdf] [Last accessed 19 June 2018]
20. Anonymous: Vision, Mission and Values of AfSBT – AfSBT. Africa Society for Blood Transfusion. 2018. Epub ahead of print [https://afsbt.org/mission-and-objectives/] [Last accessed 20 June 2018]
21. Anonymous: ACCREDITATION OVERVIEW - AfSBT. Africa Society for Blood Transfusion. 2018. Epub ahead of print [https://afsbt.org/accreditation-overview/] [Last accessed 20 June 2018]
22. Tagny CT, Diarra A, Yahaya R, et al.: Characteristics of blood donors and donated blood in sub-Saharan Francophone Africa. Transfusion 2009; 49:1592–1599
23. Asamoah-Akuoko L, Hassall OW, Bates I, et al.: Blood donors’ perceptions, motivators and deterrents in Sub-Saharan Africa–a scoping review of evidence. Br J Haematol 2017; 177:864–877
24. Lara AM, Kandulu J, Chisuwo L, et al.: Laboratory costs of a hospital-based blood transfusion service in Malawi. J Clin Pathol 2007; 60:1117–1120
25. Bates I, Manyasi G, Lara AM: Reducing replacement donors in Sub-Saharan Africa: challenges and affordability. Transfus Med 2007; 17:434–442
26. Allain J-P, Sibinga CTS: Family donors are critical and legitimate in developing countries. Asian J Transfus Sci 2016; 10:5
27. World Health Organization: Health in 2015: from MDGs, millennium development goals to SDGs, sustainable development goals. 2015: 215
28. Anonymous: General Assembly - U.N. Resolution 67/81. Global health and foreign policy Epub ahead of print [http://repository.un.org/bitstream/handle/11176/301839/A_RES_67_81-EN.pdf]. Washington, USA, United Nations, 2013: p. 6 [Last accessed 23 August 2018]
29. Anonymous: WHA resolution 63.12 - Availability, safety and quality of blood products. Geneva, World Health Organisation, 2010. Epub ahead of print [http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R12-en.pdf].: p. 4 [Last accessed 23 August 2018]
30. Dahourou H, Tapko J-B, Kienou K, et al.: Recruitment of blood donors in Burkina Faso: how to avoid donations from family members? Biologicals 2010; 38:39–42
31. Nébié K, Olinger C, Kafando E, et al.: Lack of knowledge among blood donors in Burkina Faso (West Africa); potential obstacle to transfusion security. Transfus Clin Biol 2007; 14:446–452
32. Ministry of Health BF: Activities report 2016, Centre National de Transfusion sanguine, Burkina Faso. 2017
33. Diane MK, Dembele B, Konate S: Blood collection to cover national needs in sub-Saharan Africa: the reality of the Ivory Coast. Blood Transfus 2014; 12:624
34. Reddy R: Blood donation patterns and challenges in Southern Africa. ISBT Sci Ser 2012; 7:296–299
35. Guinéenews: Difficultés dans la collecte du sang en Guinée: le Directeur du CNTS tire la sonnette d'alarme. Guinéenews 2017
36. Lund TC, Hume H, Allain JP, et al.: The blood supply in Sub-Saharan Africa: needs, challenges, and solutions. Transfus Apheres Sci 2013; 49:416–421
37. Osaro E, Charles AT: The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood. J Blood Med 2011; 2:7
38. Butler EK, Hume H, Birungi I, et al.: Blood utilization at a national referral hospital in sub-Saharan Africa. Transfusion 2015; 55:1058–1066
39. Lippi G: Interference studies: focus on blood cell lysates preparation and testing. Clin Lab 2012; 58:351
40. Sawadogo S, Nébié K, Kafando E, et al.: Preparation of red cell concentrates in low-income countries: efficacy of whole blood settling method by simple gravity in Burkina Faso. Int J Blood Transfu Immunohematol 2016; 6:20–29
41. Van Griensven J, Edwards T, De Lamballerie X, et al.: Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med 2016; 374:33–42
42. Brown JF, Rowe K, Zacharias P, et al.: Apheresis for collection of ebola convalescent plasma in Liberia. J Clin Apheresis 2017; 32:175–181
43. Ware A, Jacquot C, Tobian A, et al.: Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings. Vox Sang 2017; 113:3–12
44. Bloch EM, Shah A, Kaidarova Z, et al.: A pilot external quality assurance study of transfusion screening for HIV, HCV and HBsAG in 12 African countries. Vox Sang 2014; 107:333–342
45. Laperche S: Transfusion FAGfRiB: multinational assessment of blood-borne virus testing and transfusion safety on the African continent. Transfusion 2013; 53:816–826
46. Drew VJ, Barro L, Seghatchian J, et al.: Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries. Blood Transfus 2017; 15:512–521
47. Allain J-P, Owusu-Ofori AK, Assennato SM, et al.: Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial. Lancet 2016; 387:1753–1761
48. Fast LD, Nevola M, Tavares J, et al.: Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease? Transfusion 2013; 53:373–381
49. Owusu-Ofori S, Allain JP, Owusu-Ofori A: Prevention of transfusion-transmitted malaria. ISBT Sci Ser 2017; 12:161–167
50. Marano G, Vaglio S, Pupella S, et al.: Convalescent plasma: new evidence for an old therapeutic tool? Blood Transfus 2016; 14:152
51. Winkler AM, Koepsell SA: The use of convalescent plasma to treat emerging infectious diseases: focus on Ebola virus disease. Curr Opin Hematol 2015; 22:521–526
52. Mupapa K, Massamba M, Kibadi K, et al.: Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis 1999; 179(Suppl 1):S18–S23
53. Sahr F, Ansumana R, Massaquoi T, et al.: Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone. J Infect 2017; 74:302–309
54. Anonymous: Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks: interim guidance for national health authorities and blood transfusion services. Geneva, World Health Organisation, 2014
55. Burnouf T, Emmanuel J, Mbanya D, et al.: Ebola: a call for blood transfusion strategy in sub-Saharan Africa. Lancet 2014; 384:1347–1348
56. van Griensven J, Edwards T, Baize S, et al.: Efficacy of convalescent plasma in relation to dose of Ebola Virus Antibodies. N Engl J Med 2016; 375:2307–2309
57. Kajeguka DC, Kaaya RD, Mwakalinga S, et al.: Prevalence of dengue and chikungunya virus infections in north-eastern Tanzania: a cross sectional study among participants presenting with malaria-like symptoms. BMC Infect Dis 2016; 16:183
58. Mamoudou S, Boushab B: Hemorrhagic form of dengue fever observed at the Infectious Diseases Department CHU Yalgado Ouédraogo, Burkina Faso. Pan Afr Med J 2016; 23:168
59. Tambo E, Chuisseu PD, Ngogang JY, et al.: Deciphering emerging Zika and dengue viral epidemics: Implications for global maternal–child health burden. J Infect Public Health 2016; 9:240–250
60. Burnouf T, Conton B, Dye JM, et al.: Convalescent plasma for Ebola Virus Disease. N Engl J Med 2016; 374:2499
61. Burnouf T, Dye JM, Abayomi A, et al.: Convalescent plasma and the dose of Ebola Virus Antibodies. N Engl J Med 2017; 376:1296–1297
62. Anonymous: The State Of World Population 2014 from the UNFPA. 2014. Epub ahead of print [http://www.unfpa.org/united-nations-population-award] [Last accessed 25 June 2017]
63. Ashraf T, Sibinga SC: Blood donation and donor motivation in oman-achieving 100% voluntary non-remunerated blood donation. Vox Sang 2012; 103:92
64. Anonymous: Blood transfusion safety. Geneva, World Health Organisation, 2017. Epub ahead of print [http://www.who.int/bloodsafety/en/] [Last accessed 25 June 2017]
65. Bates I, Hassall O, Mapako T: Transfusion research priorities for blood services in sub-Saharan Africa. Br J Haematol 2017; 177:855–863
66. Nkohkwo AA, Agbor G, Asongalem E, et al.: Whole blood pathogen reduction technology and blood safety in sub-Saharan Africa: a systematic review with regional discussion. Afr J Lab Med 2016; 5:1–9
67. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al.: Cerebral oximetry in Ugandan children with severe anemia: clinical categories and response to transfusion. JAMA Pediatr 2016; 170:995–1002
68. Edwards T, Semple MG, De Weggheleire A, et al.: Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014–2015 outbreak. Clin Trials 2016; 13:13–21
69. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al.: Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: the TOTAL randomized clinical trial. JAMA 2015; 314:2514–2523
70. Mafirakureva N, Khoza S, Hassall O, et al.: Profiles of blood and blood component transfusion recipients in Zimbabwe. Blood Transfus 2015; 13:600
71. Ugwu N, Awodu O, Bazuaye G, et al.: Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria. Niger J Clin Pract 2015; 18:522–526
72. Bloch EM, Crookes RL, Hull J, et al.: The impact of human immunodeficiency virus infection on obstetric hemorrhage and blood transfusion in South Africa. Transfusion 2015; 55:1675–1684
73. Pitman JP, Basavaraju SV, Shiraishi RW, et al.: Namibia's transition from whole blood–derived pooled platelets to single-donor apheresis platelet collections. Transfusion 2015; 55:1685–1692
74. Pitman JP, Wilkinson R, Liu Y, et al.: Blood component use in a sub-Saharan African country: results of a 4-year evaluation of diagnoses associated with transfusion orders in Namibia. Transfus Med Rev 2015; 29:45–51
75. Joubert J, Joubert S, Raubenheimer J, et al.: The long-term effects of training interventions on transfusion practice: a follow-up audit of red cell concentrate utilisation at Kimberley Hospital, South Africa. Transfus Apher Sci 2014; 51:25–32
76. van den Berg K, Murphy EL, Pretorius L, et al.: The impact of HIV-associated anaemia on the incidence of red blood cell transfusion: implications for blood services in HIV-endemic countries. Transfus Apheres Sci 2014; 51:10–18
77. Sonnekus P, Louw V, Ackermann A, et al.: An audit of the use of platelet transfusions at Universitas Academic Hospital, Bloemfontein, South Africa. Transfus Apher Sci 2014; 51:44–52
78. Joubert S, Bosman M, Joubert G, et al.: The utilization of red cell concentrates at Kimberley Hospital Complex, Northern Cape Province, South Africa. Transfus Apher Sci 2013; 49:522–527
79. Osei E, Odoi A, Owusu-Ofori S, et al.: Appropriateness of blood product transfusion in the Obstetrics and Gynaecology (O&G) department of a tertiary hospital in West Africa. Transfus Med 2013; 23:160–166
80. Dosunmu A, Akinbami A, Oshinaike O, et al.: Open heart surgery: preliminary report of blood transfusion practice and haematological changes. Experience from a Nigerian tertiary teaching hospital. Niger Postgrad Med J 2011; 18:177–181
81. Figaji AA, Zwane E, Kogels M, et al.: The effect of blood transfusion on brain oxygenation in children with severe traumatic brain injury. Pediatr Crit Care Med 2010; 11:325–331
82. Arewa O: One year clinical audit of the use of blood and blood components at a tertiary hospital in Nigeria. Niger J Clin Pract 2009; 12:429–433
83. Avent M, Cory B, Galpin J, et al.: A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the management of anaemia of prematurity in a developing country. J Trop Pediatr 2002; 48:227–233